Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2023 Sep 7;14:1258855. doi: 10.3389/fphar.2023.1258855

Corrigendum: A Chinese medicine formula (Bushen Huoxue Tongluo) for the treatment of chronic subjective tinnitus: a study protocol for a pilot, assessor-blinded, randomized clinical trial

Hong Wei Zhang 1,2,*, Kammy N K Yeung 3, Michael C F Tong 3, Zhi-Xiu Lin 1,2, Waitsz W T Chang 3, Iris H-Y Ng 3, Chi Him Sum 2, Ka Chun Leung 2, Kam Leung Chan 1,2, Kit Ngan 4, Tie Jun Tong 5
PMCID: PMC10514144  PMID: 37745086

In the published article, there was an error in the Funding statement. This study is supported by Health and Medical Research Fund (HMRF), Food and Health Bureau, Hong Kong, China (No. 18190691).The correct Funding statement appears below.

“This study is supported by Health and Medical Research Fund (HMRF), Food and Health Bureau, Hong Kong, China (No. 17180941)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES